tirzepatide is it a glp 1 Compound Tirzepatide Explained: The Future of
Description
Weight loss from GLP-1 medications does not produce a disproportionate reduction in muscle mass or function in either obese mice or humans

No medications are prescribed without a medical evaluation, and patient information is never sold or shared outside of care coordination

Carlessi R, Chen Y, Rowlands J, Cruzat VF, Keane KN, Egan L, et al

It is an educational reference

Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans

The medication is broken down into smaller peptide fragments and individual amino acids by peptidases and proteases throughout the body, particularly in the kidneys and liver